These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16966695)

  • 21. Impedance-pH monitoring: new standard for measuring gastro-oesophageal reflux.
    Bredenoord AJ
    Neurogastroenterol Motil; 2008 May; 20(5):434-9. PubMed ID: 18416700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
    Mainie I; Tutuian R; Castell DO
    J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.
    Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M
    Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring.
    Sharma N; Agrawal A; Freeman J; Vela MF; Castell D
    Clin Gastroenterol Hepatol; 2008 May; 6(5):521-4. PubMed ID: 18356117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory based investigations for diagnosing gastroesophageal reflux disease.
    Dolder M; Tutuian R
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):787-98. PubMed ID: 21126694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
    Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
    J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Con: Impedance-pH testing does not commonly alter management of GERD.
    Richter JE
    Am J Gastroenterol; 2009 Nov; 104(11):2667-9. PubMed ID: 19888231
    [No Abstract]   [Full Text] [Related]  

  • 28. Increase of weakly acidic gas esophagopharyngeal reflux (EPR) and swallowing-induced acidic/weakly acidic EPR in patients with chronic cough responding to proton pump inhibitors.
    Kawamura O; Shimoyama Y; Hosaka H; Kuribayashi S; Maeda M; Nagoshi A; Zai H; Kusano M
    Neurogastroenterol Motil; 2011 May; 23(5):411-8, e172. PubMed ID: 21210893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
    Hirano I
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux].
    Bredenoord AJ; Smout AJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2548-52. PubMed ID: 19174935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease.
    Slaughter JC; Goutte M; Rymer JA; Oranu AC; Schneider JA; Garrett CG; Hagaman D; Vaezi MF
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):868-74. PubMed ID: 21782769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
    Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP
    Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance.
    Tutuian R; Castell DO
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():27-37. PubMed ID: 16939430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extra-oesophageal reflux: state of the knowledge base.
    Ah-See K; Wilson J
    Clin Otolaryngol; 2012 Feb; 37(1):9-16. PubMed ID: 22433134
    [No Abstract]   [Full Text] [Related]  

  • 35. The relevance of reflux monitoring off therapy.
    Savarino E; Zentilin P; Savarino V
    Am J Gastroenterol; 2011 Aug; 106(8):1558-9; author reply 1559. PubMed ID: 21811280
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of proton pump inhibitor (PPI) treatment in obstructive sleep apnea syndrome: an esophageal impedance-pHmetry study.
    Ermis F; Akyuz F; Arici S; Uyanikoglu A; Yakar F; Pinarbasi B; Demir K; Ozdil S; Besisik F; Kaymakoglu S; Boztas G; Cuhadaroglu C; Mungan Z
    Hepatogastroenterology; 2011; 58(110-111):1566-73. PubMed ID: 21940322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors.
    Hershcovici T; Fass R
    Curr Opin Gastroenterol; 2010 Jul; 26(4):367-78. PubMed ID: 20571388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients.
    Ribolsi M; Emerenziani S; Borrelli O; Balestrieri P; Addarii MC; Petitti T; Cicala M
    Scand J Gastroenterol; 2012 Nov; 47(11):1266-73. PubMed ID: 22954058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.
    Blondeau K; Boecxstaens V; Van Oudenhove L; Farré R; Boeckxstaens G; Tack J
    Neurogastroenterol Motil; 2011 Aug; 23(8):724-e327. PubMed ID: 21535319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.